The LKB1 tumor suppressor negatively regulates mTOR signaling
Beth Israel Deaconess Medical Center · Harvard University · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,065
total citations
- FWCI
- 21.45
- Percentile
- 100%
- References
- 69
Citations per year
Authors
7- RJReuben J. ShawCorresponding
Beth Israel Deaconess Medical Center, Harvard University
- NBNabeel Bardeesy
Harvard University, Dana-Farber Cancer Institute
- BDBrendan D. Manning
Beth Israel Deaconess Medical Center, Harvard University
- LVLyle V. Lopez
Harvard University, Dana-Farber Cancer Institute
- MKMonica Kosmatka
Beth Israel Deaconess Medical Center, Harvard University
Topics & keywords
Topics
Keywords
- PI3K/AKT/mTOR pathway
- PTEN
- AMPK
- RPTOR
- TSC2
- Cancer research
- mTORC2
- Suppressor
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.